Anlon Healthcare Limited (NSE:AHCL)

India · Delayed Price · Currency is INR

19.57

+2.03 (11.57%)

At close: Sep 11, 2026

Anlon Healthcare Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	2,262	1,720	1,203	666.16	1,131	573.89
Revenue Growth	95.37%	42.95%	80.64%	-41.09%	97.04%	259.14%
Gross Profit	792.73	651.93	359.1	317.42	242.04	135.84
Operating Income	547.05	463.18	306.52	138.75	112.65	40.2
Net Income	316.29	285.14	205.18	96.57	58.2	-1.08
Earnings Per Share	0.76	5.99	6.37	0.67	0.48	-0.01
EPS Growth	-	-5.86%	853.02%	37.73%	-	-

Revenue by Geography

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	1,685	1,164	599.73	1,009	476.81
Export	34.59	38.97	66.11	120.26	94.61
Total	1,720	1,203	665.84	1,129	571.43

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	43.76	43.76	23.59	31.2	45.31	32.96
Total Debt	436.53	436.53	665.54	812.48	703.24	623.84
Net Cash (Debt)	-392.77	-392.77	-641.96	-781.29	-657.93	-590.88
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.94	-8.26	-19.92	-5.41	-5.48	-4.92

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	-794.4	-225.52	-32.26	-28.5	-17.54
Capital Expenditures	-	-364.19	-5.29	-35.32	-3.72	-4.78
Free Cash Flow	-	-1,159	-230.81	-67.58	-32.22	-22.32
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	35.04%	37.90%	29.84%	47.65%	21.40%	23.67%
Operating Margin	24.18%	26.93%	25.47%	20.83%	9.96%	7.00%
Pretax Margin	22.62%	24.71%	22.34%	14.64%	6.18%	-0.19%
Profit Margin	13.98%	16.58%	17.05%	14.50%	5.15%	-0.19%
FCF Margin	-	-67.36%	-19.18%	-10.14%	-2.85%	-3.89%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 12, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	25.76	20.76	-	-	-	-
PS Ratio	4.60	3.44	-	-	-	-